CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Executive Officer sold 14,075 shares at $4.58 ($64,464)
- 4 Open-market sale Chief Data Officer sold 5,342 shares at $4.58 ($24,466)
- 4 Open-market sale General Counsel sold 5,915 shares at $4.58 ($27,091)
- 4 Open-market sale Chief Information Officer sold 7,297 shares at $4.58 ($33,420)
- 4 Open-market sale Chief Scientific Officer sold 5,915 shares at $4.58 ($27,091)
- 4 Open-market sale Chief Financial Officer sold 5,915 shares at $4.58 ($27,091)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Information Officer sold 554 shares at $3.97 ($2,199)
- 4 Option exercise Director acquired 37,549 shares (option exercise)
- 4 Planned sale Director sold 34,211 shares at an average $6.74 ($230,469)
- 4 Planned sale General Counsel sold 29,591 shares at an average $6.80 ($201,133)
- 4 Planned sale Chief Information Officer sold 16,473 shares at an average $7.27 ($119,678)
- 4 Planned sale Chief Data Officer sold 13,419 shares at an average $7.42 ($99,565)
- 4 Planned sale Chief Financial Officer sold 2,431 shares at $8.06 ($19,594)
- 4 Open-market sale Director sold 100 shares at $7.69 ($769)
- 4 Open-market sale Chief Executive Officer sold 26,224 shares at $7.41 ($194,320)
- 4 Open-market sale Chief Financial Officer sold 5,730 shares at $7.41 ($42,459)
- 4 Open-market sale Director sold 93 shares at $7.12 ($662)
- 4 Open-market sale Director sold 95 shares at $7.32 ($695)
- 4 Open-market sale Chief Executive Officer sold 12,075 shares at $7.32 ($88,389)
Page 8 of 16 · 313 filings